Although inflammation has been shown to be a hallmark of cancer [53], and several pro-inflammatory cytokines play a role in tumor progression [54], IFN-γ and IL-6 have been described as key elements in host anti-tumor immune response [42]. The gene discussed is IL6; the disease is cancer.